Li Auto delivered a modestly robust Q2, beating top line estimates, but seeing revenue pressure due to falling volumes. LI improved its vehicle margin to 9.4% in Q2, and is therefore still trailing the EV competition. Nonetheless, Li Auto's financial and operating performance could be improving if new product launches, such as refreshed L-Series models and the new Li MEGA, become a success.
USD/JPY has staged a major bearish reversal, breaking below its 200-day moving average as the Japanese yen strengthens sharply. Support from US Treasury Secretary Scott Bessent for Japanese action, hawkish BoJ commentary and renewed FX intervention risk have reinforced the move.
Methanex has transformed into a more durable, cash-generating entity by acquiring OCI Global's methanol business and idling structurally disadvantaged facilities. MEOH's North American production focus, global logistics network, and reliable supply provide a competitive advantage amid global supply disruptions and tightening methanol markets. The company trades at steep valuation discounts (P/E 6.98, EV/EBITDA 4.74, P/CF 3.25) despite improved asset quality, liquidity, and cash flow predictability.
Japan listed Remixpoint sold DOGE, ETH, SOL and XRP, booking gains on three assets while taking a $21K DOGE loss and shifting to Bitcoin.
Bitcoin was trading at $77,121 on Thursday, having clawed back much of its summer losses in a sharp August rally. The cryptocurrency gained roughly 24% during August alone, rising from around $62,600 at the start of the month to a peak of $80,797 on August 25.
Analysts see the software company continuing to benefit from the artificial-intelligence revolution.
Moderna receives a speculative Strong Buy rating after phase 3 melanoma data strengthens its oncology platform thesis. MRNA's upside hinges on Intismeran's ability to scale across multiple tumor types, not just melanoma. The 50/50 partnership with Merck provides both distribution strength and shared economics for Intismeran.
On September 2, U.S. investor demand for cryptocurrency ETFs was clearly divided, with Bitcoin drawing in new investment, while Ethereum, XRP, and Solana products all saw daily net outflows.
Hyperliquid's HIP-4 outcome volume tripled after outside deployment opened, but incentives and U.S. regulatory barriers complicate the growth.
Gem Diamonds Limited (LSE:GEMD, OTC:GMDMF) shares saw a significant upward movement on Thursday following the release of its half-year results and a firm 'buy' reiteration from Panmure Liberum. The shares traded up 70% to 11p as the broker held its 'buy' stance and 13p target price, digesting the miner's improved financial and operational footprint.
Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013, FRA:H7T2) won ringing endorsements from City brokers on Thursday after securing a blockbuster licensing agreement with GSK PLC (LSE:GSK, NYSE:GSK), exposing what analysts regard as a deep valuation disconnect. The shares leapt 15% to 205.84p as Cavendish and Panmure Liberum reiterated their respective 'buy' ratings, arguing that the market continues to overlook the biotech's expanding oncology pipeline.
Japan-listed Remixpoint has sold its entire altcoin portfolio and will now hold only bitcoin as part of a more concentrated crypto strategy. The company exited ETH, SOL, XRP, and DOGE positions for about $5.54 million (¥879 million), locking in roughly $743,270 (¥118 million) in profit.
BTC rose 0.76% since midnight as a softer dollar lifted equities and metals alongside crypto, while ARB and PONS pushed higher for a third session.
MSA Safety delivered Q2 2026 results with revenue of $503M, beating consensus by $7M and adjusted EPS up 24% year-over-year. Adjusted operating margin expanded 270 bps to 24.1%, and free cash flow reached $83M, reflecting strong productivity and pricing actions. Detection segment revenue rose 4%, driven by the M&C TechGroup acquisition and robust Americas organic growth, offset by international weakness.
The CFTC says that CME is unable to prove competitive injury from Kalshi's Bitcoin perpetual futures. The case may impact how regulators in the United States regulate crypto perpetuals.
Summit Therapeutics is positioned as a high-conviction buy into the November 2026 FDA PDUFA decision for ivonescimab in NSCLC. SMMT's ivonescimab demonstrates robust PFS and statistically significant OS benefits in multiple Phase III trials, supporting best-in-class potential versus PD-1 monotherapy. Financials reflect intentional capital deployment, with $690M+ cash and 4–5 quarters of runway to fund late-stage clinical catalysts and regulatory milestones.
Semtech ( SMTC ) is a $12 billion supplier of high-performance analog, mixed-signal semiconductor, and advanced wireless products. The company plays a pivotal role in enabling physical artificial intelligence infrastructure, optical interconnects, low-power IoT networks, and circuit protection systems.
Gold Price Forecast: XAU/USD recovery, likely to be challenged around $4,470
A Coldcard attacker moved about 10% of stolen Bitcoin through THORChain into ETH as researchers traced a new Ethereum destination.
As Nvidia Corp. (NASDAQ: NVDA) stock rose nearly 6% over the past 30 days, driven by solid demand in the Artificial Intelligence (AI) space, Aksel Kibar, a popular chartist and a former fund manager, expects a rally towards its former all-time high (ATH).
Fidelity says future quantum computers could expose Bitcoin private keys, and a new hash-based signature system may offer protection at the cost of network speed.
PBI and CRCT made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 3, 2026.
Bitcoin (BTC) is currently trading at the $77.5K mark. The short-term momentum is weaker than the long-term.
Don Skalka spent two decades as an operations specialist at the largest oil refinery in the Midwest, a well-paid job he enjoyed so much he brought his own children into the work.
0.8600 under pressure: EUR/GBP at two-month highs following Services PMIs
USA Rare Earth offers high-upside exposure to critical rare earths, with national security and defense demand as a key driver. USAR's Round Top mine is set to supply essential elements like Nd, Pr, Dy, and gallium, supporting vertical integration and domestic supply chains. Financially, USAR holds $1.53B in cash and manageable liabilities, but is pre-revenue, burning cash, and faces execution and dilution risks.
Microsoft (NASDAQ: MSFT) has declared its next quarterly dividend of $0.91 per share payable Thursday, September 10, 2026, to shareholders of record on August 20, 2026.
USD/CAD price outlook: US Dollar/Canadian Dollar navigating between Arc levels
Nvidia is rated Buy, driven by its ability to capture $40B in revenue per gigawatt with the Vera Rubin platform. NVDA's growth model is shifting from selling accelerators to capturing more of the AI factory bill of materials, expanding system content and economics. Despite gross margin compression to 72-73%, profit per gigawatt rises as the company controls more system components and value per constrained GW.
LIT could get a token buyback boost as revenue surges 24%.